Lisa Osborne retweeted
We've been awarded a 2025 @EdisonAwards for the third consecutive year 💡 Viz HCM, our AI software solution, is designed to detect and triage patients with signs of hypertrophic cardiomyopathy (HCM). Read more 👉 viz.ai/news/viz-ai-wins-2025…
#EdisonAwards #AIinHealthcare #Innovation
Lisa Osborne retweeted
🙌 We are proud to announce that Viz HCM is a finalist in the New Brand Launch category for the 2024 @FiercePharma Marketing Awards. We are thrilled our brand campaign is receiving this prestigious recognition. digitalpharmaeast.com/digita…
CEO Geoff Gill will discuss how the #Verisense research-grade #SmartWatch, #DigitalHealthPanel & #DigitalBiobank can advance #brain research at 4 pm today @BU_Computing. More info: spr.ly/6016ZA2nn Verisense.net
34
#Verisense CEO Geoff Gill is participating in a thought-provoking @BU_Computing panel discussion on #DataScience & #ArtificialIntelligence approaches to improve #brain health 4-6 pm ET Thurs. Addtl info: spr.ly/6016ZA2nn
28
Verisense Health, a Shimmer Research Spin-off, Launches as a Digital Health Software and Data Management Company biopharmadive.com/press-rele… via @BioPharmaDive
54
Lisa Osborne retweeted
BioIVT Acquires Biospecimen Firm Fidelis Research. Bulgaria-based Fidelis Research operates a network of 85 clinical biospecimen collection sites throughout Southeastern Europe. ow.ly/kEoS1043tOT
Lisa Osborne retweeted
Certara’s Simcyp COVID-19 Vaccine Model, a 2021 R&D 100 Awards winner soundcloud.com/user-49411224…
R&D 100 winner of the day: Certara’s COVID-19 Vaccine Model rdworldonline.com/rd-100-win…
1
Congratulations @Certara for being named a finalist in the @EdisonAwards! Delighted to see your Simcyp COVID-19 Vaccine Model recognized.edisonawards.com/finalists20… #EdisonAwards #EA2022
3
Ipsos, IVP Research Labs, Schlesinger Group to Employ Shimmer’s NeuroLynQ™ to Analyze Super Bowl Audience Reaction Live @MarTechSeries martechseries.com/analytics/…
Lisa Osborne retweeted
Dr. Aryeh Shander has joined Accumen's Medical Advisory Council as our newest medical director, where he will support our best-in-class comprehensive patient blood management programs. Read full release here! hubs.ly/Q012Qrxm0 #PatientBloodManagement #MedTwitter #healthcare
Lisa Osborne retweeted
Check out the More Than a Refresh podcast episode, where President of Shimmer Americas talks how #wearables can improve #healthcare, research, and #clinicaltrials!
A new episode of More Than a Refresh podcast is live. Listen in as @linuxhiker chats with @ShimmerSensing and #OWEAR's Geoffrey Gill about the line between user privacy and effective #wearables, #neuromarketing, and peer review. @PostgresWorld
anchor.fm/more-than-a-refres…
Lisa Osborne retweeted
Congratulations Piet van der Graaf who has been named the 2021 Leadership Award Recipient by the International Society of Pharmacometrics @ISOP1 !
Lisa Osborne retweeted
#Healthcare has the highest number of attacks by ransomware than any other industry. What's causing this uptick in operational disruptions and how can Accumen’s partnership with @DiscoverAUI increase your organization’s resilience? #cyberattack
hubs.ly/H0V8YZ70
Lisa Osborne retweeted
BioIVT Acquires Tissue Solutions Ltd., a UK-based Virtual Biobank dlvr.it/S5VcZr
Lisa Osborne retweeted
The utilization & cost of blood products is on the rise as hospitals manage high acuity patients & a shrinking blood donor pool associated with #COVID19 #blooddonation may be the 1st idea that comes to mind, but it's only 1 part of a multi-faceted approach hubs.ly/H0TRDvb0
Lisa Osborne retweeted
The challenge of providing rapid, effective protection against Covid-19
ddw-online.com/rising-to-the…
#Covid19
Lisa Osborne retweeted
This is the final day to join Dr. Raju Khatri at BioIVT as he talks about his research on the first human study on the impact of pregnancy hormones on multiple CYP proteins and the metabolism of nifedipine. Save your seat now! #drugdevelopment hubs.ly/H0KHq_q0
Lisa Osborne retweeted
at #SCOPE2021, @ShimmerSensing's Geoff Gill discusses how #Verisense enables you to Meet all Endpoint Needs with a Single Platform. Join the talk today at 12:35pm EST in the Solutions Theatre
BioIVT Unveils COVID-19 Panel to Accelerate Vaccine-Generated Immune Response Research labmanager.com/product-news/…























